US 12403202
Dosage of claudin-6 conjugates for cancer treatment
granted A61KA61K47/68031A61K47/6849
Quick answer
US patent 12403202 (Dosage of claudin-6 conjugates for cancer treatment) held by The Regents of the University of California expires Mon Aug 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Sep 02 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 27
- CPC classes
- A61K, A61K47/68031, A61K47/6849, A61K47/6851, A61P